Navigation Links
Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7
Date:1/25/2009

Dr. Ali Rashidee will Serve a Two-Year Term as Co-Chair of the PSWG

SAN FRANCISCO, Jan. 26 /PRNewswire/ --

*NOTE TO EDITORS: Please note that this release was issued previously on January 22, 2009 containing factual errors which have been corrected herein.

Dr. Ali Rashidee MD, MS, the Director for Safety and Risk Management at Quantros, has been elected Co-Chair for the HL7 Patient Safety Work Group (PSWG). This international healthcare information organization's ongoing mission is to simplify the implementation of interfaces between health care applications for the exchange of key sets of clinical data minimizing the need for custom interface programming and program maintenance. The HL7 PSWG is the body tasked with developing the data interchange standard in the patient safety arena.

Dr. Rashidee has spent a large part of his career enhancing healthcare informatics for the betterment of healthcare safety and quality including tenure as a Co-Chair the HL7 PSWG from 2003-2005. In his current role at Quantros, Dr. Rashidee is responsible for ensuring Quantros Safety and Risk Management (SRM) solutions contain an extensive taxonomy and classification schema in alignment with national and international standards along with the business requirements for managing safety in various settings. More than 900 facilities throughout the United States use the SRM application daily to help reduce preventable medical errors and provide a safer environment of care. As a Co-Chair of the HL7 PSWG, Dr. Rashidee's knowledge and experience in patient safety will help further the group's data interoperability endeavors, both nationally and internationally.

"One of the key factors to improving patient safety is the ability for healthcare leadership to have right data presented across the systems to make clinically and fiscally sound decisions about environment of care and process improvement," according to Dr. Rashidee. "The HL7 PSWG is focused on defining data interchange standards for patient safety that breaks down data silos, facilitates interoperability and enables systems to provide a common language across healthcare technology solutions. I am honored to have been elected as a Co-Chair to help lead this very important endeavor."

"The work of the HL7 PSWG is a vital component for creating system interoperability in the area of patient safety," states Sanjaya Kumar, MD, President and CEO for Quantros. "Dr. Rashidee's experience in clinical informatics and patient safety taxonomy development and management with organizations such as AHRQ, PSO-PPC, NHSN, WHO and the FDA are a perfect complement to this team and its goals."

About Quantros

Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' Web-based applications and value-added services provide a standard platform that creates actionable knowledge and guided direction to help clients save lives, improve quality and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros technology solutions every day.

Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology engineers.

Quantros website: www.quantros.com

About HL7

Founded in 1987, Health Level Seven, Inc. (www.HL7.org) is a not-for-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare.

HL7's endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technologies; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Sanofi-aventis R&D; Siemens Healthcare; St. Jude Medical; Sunquest Information Systems; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.

Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and Uruguay.

HL7 Website: www.hl7.org


'/>"/>
SOURCE Quantros
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
2. Quantros Expanding Support for Alternative Web Browsers
3. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
4. Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
5. Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety
6. Quantros and ISMP to Partner on PSO Initiatives
7. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
8. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
9. HealthInsuranceFinders.com Launches Video Contest for Young Directors
10. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
11. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... OK (PRWEB) , ... March 29, 2017 , ... ... now receive FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with ... straighten teeth efficiently, compared to traditional orthodontic treatment. Depending on each patient’s case, ...
(Date:3/29/2017)... ... March 29, 2017 , ... How big ... outpatient facilities, and who are the most active developers? , In the ... Healthcare Real Estate Insights (HREI) found that outpatient medical real estate development projects ...
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a clinical ... through treatment, today announced that Carmine N. Stengone , president ... at the Needham & Company 16 th Annual Healthcare Conference ... PDT) at the Westin Grand Central Hotel in New ... ...
(Date:3/29/2017)... EAST HANOVER, N.J. , March 29, 2017 ... and Drug Administration (FDA) has accepted the company,s ... review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen ... refractory (r/r) pediatric and young adult patients with ... first BLA submission by Novartis for a CAR-T. ...
(Date:3/29/2017)... March 29, 2017 Today, CVS Health officials (NYSE: ... Reynolds , Department of Public Health Director Gerd Clabaugh ... Lukan in announcing the availability of the opioid overdose-reversal ... in Iowa.  CVS Health has established a standing order with ... Pharmacy to expand access to the medication in the state.   ...
Breaking Medicine Technology: